A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers

NCT02005211 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers

Interventions

DRUG: AZD3293
DRUG: Placebo

Sponsor

AstraZeneca